Skip to main content
    B

    Bladex Inc. (BLX)

    Official site

    FINANCIAL SERVICES • BANKS - REGIONAL • NYSE

    $49.45
    -1.10 (-2.18%)

    Market Cap: $1.88B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Bladex Inc. (BLX) Earnings: Report Dates and Results

    Updated Oct 26, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Bladex (BLX) is expected to report earnings on Feb 10, 2027. In the quarter ended Sep 30, 2026, Bladex reported EPS of $1.48. It beat the EPS estimate in each of the 11 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    58%(19/33)
    Avg Surprise
    -7.75%
    Streak
    11 Q

    Next Report

    BLX has an expected report date of Feb 10, 2027.

    BLX Earnings Call

    The latest BLX earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 33 quarters below that had an estimate, BLX beat 19, missed 13 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $234.37M, up 12.1% from $209.03M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$1.48N/AN/AN/AN/A+0.2%N/AN/AOct 26, 2026$234.37M
    Jun 30, 2026$1.77N/AN/AN/AN/A+2.3%N/AN/AJul 27, 2026$224.71M
    Mar 31, 2026$1.31N/AN/AN/AN/A-6.7%N/AN/AApr 27, 2026$83.10M
    Dec 31, 2025$1.50N/AN/AN/AN/A+7.4%N/AN/AFeb 12, 2026$88.80M
    Sep 30, 2025$1.48N/AN/AN/AN/A+2.5%N/AN/AOct 28, 2025$209.03M
    Jun 30, 2025$1.73N/AN/AN/AN/A+26.9%N/AN/AAug 4, 2025$216.73M
    Mar 31, 2025$1.40N/AN/AN/AN/A0.0%N/AN/AMay 5, 2025$202.11M
    Dec 31, 2024$1.40$1.07N/A+30.84%Beat+10.2%N/AN/AFeb 27, 2025$190.04M
    Sep 30, 2024$1.44$1.12N/A+28.62%Beat+15.2%N/AN/AOct 29, 2024$209.63M
    Jun 30, 2024$1.36$1.13N/A+20.61%Beat+33.6%N/AN/AJul 23, 2024$207.65M
    Mar 31, 2024$1.40$1.14N/A+22.84%Beat+37.3%N/A0 up, 0 downApr 19, 2024$203.28M
    Dec 31, 2023$1.27$1.20N/A+5.83%Beat+49.4%N/A0 up, 0 downFeb 21, 2024$206.17M
    Sep 30, 2023$1.25$1.23$1.23 - $1.23+1.63%Beat+68.9%10 up, 0 downOct 19, 2023$193.67M
    Jun 30, 2023$1.02$0.91$0.82 - $0.91+12.09%Beat+61.9%20 up, 0 downJul 20, 2023$162.42M
    Mar 31, 2023$1.02$0.84$0.84 - $0.84+21.43%Beat+229.0%11 up, 0 downApr 19, 2023$149.93M
    Dec 31, 2022$0.85$0.65$0.65 - $0.65+30.77%Beat+57.4%10 up, 0 downFeb 27, 2023$53.19M
    Sep 30, 2022$0.74$0.69$0.69 - $0.69+7.25%Beat+76.2%10 up, 0 downNov 2, 2022$98.83M
    Jun 30, 2022$0.63$0.49$0.49 - $0.49+28.57%Beat+75.0%10 up, 0 downAug 3, 2022$68.27M
    Mar 31, 2022$0.31$0.43$0.43 - $0.43-27.91%Miss-3.1%10 up, 0 downMay 4, 2022$40.43M
    Dec 31, 2021$0.54$0.44N/A+22.73%Beat+35.0%N/A0 up, 0 downFeb 22, 2022$30.57M
    Sep 30, 2021$0.42$0.41$0.41 - $0.41+2.44%Beat+7.7%11 up, 0 downOct 29, 2021$39.52M
    Jun 30, 2021$0.36$0.34$0.34 - $0.34+5.88%Beat-21.7%1N/AJul 28, 2021$38.76M
    Mar 31, 2021$0.32$0.40$0.40 - $0.40-20.00%Miss-30.4%1N/AMay 5, 2021$35.98M
    Dec 31, 2020$0.40$0.44N/A-9.09%Miss-28.6%N/AN/AFeb 12, 2021$25.31M
    Sep 30, 2020$0.39$0.37$0.37 - $0.37+5.41%Beat-25.0%1N/AOct 27, 2020$42.41M
    Jun 30, 2020$0.46$0.44N/A+4.55%Beat-17.9%1N/AJul 28, 2020$42.69M
    Mar 31, 2020$0.46$0.52$0.52 - $0.52-11.54%Miss-14.8%1N/AApr 15, 2020$61.95M
    Dec 31, 2019$0.56$0.56N/A0.00%In line+7.7%N/AN/AFeb 14, 2020$33.37M
    Sep 30, 2019$0.52$0.57$0.53 - $0.57-8.77%MissN/A2N/AOct 18, 2019$68.36M
    Jun 30, 2019$0.56$0.55$0.55 - $0.55+1.82%Beat+33.3%1N/AJul 19, 2019$76.23M
    Mar 31, 2019$0.54$0.51$0.51 - $0.51+5.88%Beat+45.9%1N/AApr 17, 2019$76.66M
    Dec 31, 2018$0.52$0.43$0.43 - $0.43+20.93%Beat0.0%1N/AFeb 28, 2019$35.41M
    Sep 30, 2018-$1.03$0.54$0.47 - $0.54-290.74%Miss-298.1%2N/AOct 25, 2018$12.70M
    Jun 30, 2018$0.42$0.57$0.52 - $0.57-26.32%Miss-4.5%2N/AJul 20, 2018$64.91M
    Mar 31, 2018$0.37$0.58$0.51 - $0.58-36.21%Miss-38.3%2N/AApr 20, 2018$59.66M
    Dec 31, 2017$0.52$0.55$0.54 - $0.55-5.45%Miss+52.9%2N/AFeb 9, 2018$34.61M
    Sep 30, 2017$0.52$0.56$0.56 - $0.56-7.14%Miss-27.8%2N/AOct 20, 2017$58.14M
    Jun 30, 2017$0.44$0.63$0.61 - $0.65-30.16%Miss-21.4%2N/AJul 21, 2017$61.18M
    Mar 31, 2017$0.60$0.68N/A-11.76%Miss-16.7%N/AN/AApr 21, 2017$59.36M
    Dec 31, 2016$0.34$0.69N/A-50.72%Miss-47.7%N/AN/AFeb 17, 2017$86.67M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $6.11, up 9.0% from the year before. It was $2.34 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$6.11+9.0%
    Dec 31, 2024$5.60+22.9%
    Dec 31, 2023$4.56+80.2%
    Dec 31, 2022$2.53+54.3%
    Dec 31, 2021$1.64-4.1%
    Dec 31, 2020$1.71-21.6%
    Dec 31, 2019$2.18+678.6%
    Dec 31, 2018$0.28-86.5%
    Dec 31, 2017$2.08-11.1%
    Dec 31, 2016$2.34N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 5,900 words across 7 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20265,9267
    2026Q2Jun 30, 20265,0788
    2026Q1Mar 31, 20265,7779
    2025Q4Dec 31, 20255,7037
    2025Q3Sep 30, 20257,55310
    2025Q2Jun 30, 20254,8698
    2025Q1Mar 31, 20254,9497
    2024Q4Dec 31, 20246,6539

    2026Q3 Earnings Call

    Opening remarks

    Jorge Salas CEO Good morning, everyone, and thank you for joining us today to discuss Bladex's results for the third quarter of 2026. I will begin with the key highlights. Annette, our CFO, will then take the call to walk you through the financial results in more detail. After that, I will return with an update on strategy and our outlook for the rest of the year. Finally, we will open the call for questions. This was an outstanding quarter for Bladex. Our commercial portfolio and net interest income both reached new record levels. Net interest income grew significantly from a year ago, and we delivered strong earnings. We did this while maintaining strong credit quality, further improving the portfolio's risk profile as stage 2 exposures declined, and preserving a strong capital position. It is an encouraging combination of financial KPIs as we enter the final part of the year. Our commercial portfolio reached a record of $15 billion, up 15% from the second quarter and 38% from a year ago. The quarter included a $1 billion one-year sovereign loan to the Republic of Panama in support of the government's liability management program. This was a one-time opportunity distinct from the transactions we typically originate. It is a sovereign exposure to Panama, which S&P and Moody's rate investment grade, with relatively low capital consumption for its size and a spread well above the sovereign bond curve. This transaction clearly demonstrates our ability to execute at scale, supported by our funding flexibility. Even excluding that single Panama sovereign loan, loans grew 7% from the second quarter and 29% from a year ago. That growth included trade and working capital financing with established clients, as well as medium-term financing for acquisitions and energy projects, mostly in Colombia and Argentina. Needless to say, we have not relaxed our underwriting standards to achieve this growth. Most of the growth this quarter came from the higher-grade segments, where we found attractive arbitrage opportunities. We know the sponsors, we understand the exposures, and we know the risks. Competition for high-quality assets continued to pressure lending spreads across the region. Latin American assets continue to attract investors' interest, supported by the region's relative distance from major conflicts and its role as a supplier of energy and other commodities. Regional sovereign risk premiums remain near historical lows. Net interest income reached a record of $79.8 million, up 9% from the second quarter, and net interest margin rose to 2.30%. It is worth mentioning, however, that this quarter's margin improvement reflected lower funding costs and a temporary benefit from loan prepayments, even as lending spreads remain under pressure. Annette will comment more on that shortly. As planned, deposits continue to grow.

    Frequently Asked Questions About BLX

    When is Bladex's next earnings date?

    Bladex's next earnings report is expected for Feb 10, 2027.

    How often does BLX beat earnings estimates?

    Bladex beat the EPS estimate in each of the 11 most recent quarters that had an estimate, with an average surprise of +19.13%.